Pentixapharm Holding Ag (PTP.D.IX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | ||||
| Income taxes - deferred | -3,751 | N/A | N/A | N/A |
| Accounts receivable | -7,583 | N/A | N/A | N/A |
| Other Working Capital | -6,719 | N/A | N/A | N/A |
| Other Operating Activity | 13,725 | 2,127 | -2,198 | -1,373 |
| Operating Cash Flow | $-4,328 | $2,127 | $-2,198 | $-1,373 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1 | -4,815 | -4,046 | -2,730 |
| Net Acquisitions | -470 | -531 | 0 | 0 |
| Other Investing Activity | 8,707 | 0 | -4,070 | 0 |
| Investing Cash Flow | $8,236 | $-5,346 | $-8,116 | $-2,730 |
| Cash Flows From Financing Activities | ||||
| Common Stock Issued | 19,274 | 25,661 | 0 | 5,289 |
| Other Financing Activity | 0 | -13,827 | 9,013 | -1 |
| Financing Cash Flow | $19,274 | $11,834 | $9,013 | $5,288 |
| Beginning Cash Position | 50 | 1,086 | 2,387 | 1,202 |
| End Cash Position | 23,232 | 9,701 | 1,086 | 2,387 |
| Net Cash Flow | $23,182 | $8,615 | $-1,301 | $1,185 |
| Free Cash Flow | ||||
| Operating Cash Flow | -4,328 | 2,127 | -2,198 | -1,373 |
| Capital Expenditure | -1 | -4,940 | -4,046 | -2,730 |
| Free Cash Flow | -4,329 | -2,813 | -6,244 | -4,103 |